MX375720B - Proceso para preparacion de 2-(6-nitropiridin-3-il)-9h-dipirido[2,3-beta;3',4'-d]pirrol. - Google Patents

Proceso para preparacion de 2-(6-nitropiridin-3-il)-9h-dipirido[2,3-beta;3',4'-d]pirrol.

Info

Publication number
MX375720B
MX375720B MX2019002362A MX2019002362A MX375720B MX 375720 B MX375720 B MX 375720B MX 2019002362 A MX2019002362 A MX 2019002362A MX 2019002362 A MX2019002362 A MX 2019002362A MX 375720 B MX375720 B MX 375720B
Authority
MX
Mexico
Prior art keywords
group
formula
compound
preparation
sub
Prior art date
Application number
MX2019002362A
Other languages
English (en)
Other versions
MX2019002362A (es
Inventor
Bjoern Bartels
Dieter Muri
Matthias Koerner
Philipp Cueni
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2019002362A publication Critical patent/MX2019002362A/es
Publication of MX375720B publication Critical patent/MX375720B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a un proceso para la preparación del compuesto de fórmula I, (ver Fórmula) comprendiendo el proceso: a) el acoplamiento de un compuesto de fórmula 2 (ver Fórmula) en la que se selecciona un grupo saliente O-SO2-R de entre grupo trifilato, grupo tosilato, grupo mesilato, grupo besilato, grupo nosilato o grupo brosilato, con un ácido borónico, un trifluoroborato o un éster de ácido borónico adecuado, bajo argón y en presencia de un catalizador y una base en un solvente adecuado y después aislar el producto en forma de una sal de adición de ácido, proporcionando el compuesto de fórmula Ia (ver Fórmula) y b) convertir la sal de adición de ácido de fórmula Ia en la que el ácido HX comprende ácidos orgánicos o inorgánicos adecuados en el compuesto de fórmula I (ver Fórmula) mediante tratamiento con por lo menos un equivalente estequiométrico de una base adecuada.
MX2019002362A 2016-09-09 2017-09-04 Proceso para preparacion de 2-(6-nitropiridin-3-il)-9h-dipirido[2,3-beta;3',4'-d]pirrol. MX375720B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16187960 2016-09-09
PCT/EP2017/072062 WO2018046428A1 (en) 2016-09-09 2017-09-04 Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole

Publications (2)

Publication Number Publication Date
MX2019002362A MX2019002362A (es) 2019-06-17
MX375720B true MX375720B (es) 2025-03-04

Family

ID=56936288

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019002362A MX375720B (es) 2016-09-09 2017-09-04 Proceso para preparacion de 2-(6-nitropiridin-3-il)-9h-dipirido[2,3-beta;3',4'-d]pirrol.

Country Status (17)

Country Link
US (1) US11306093B2 (es)
EP (1) EP3510031B1 (es)
JP (1) JP6997769B2 (es)
KR (1) KR102502701B1 (es)
CN (1) CN109689653B (es)
AR (1) AR109586A1 (es)
AU (1) AU2017324297B2 (es)
BR (1) BR112019004091B1 (es)
ES (1) ES2847903T3 (es)
HR (1) HRP20210145T1 (es)
IL (1) IL265013B (es)
MX (1) MX375720B (es)
PL (1) PL3510031T3 (es)
SG (1) SG11201901983PA (es)
SI (1) SI3510031T1 (es)
TW (1) TWI753009B (es)
WO (1) WO2018046428A1 (es)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044152A1 (es) * 2003-05-09 2005-08-24 Bayer Corp Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad
FR2876377B1 (fr) * 2004-10-11 2007-03-16 Univ Claude Bernard Lyon Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes
EP2247558B2 (en) 2008-02-14 2024-07-03 Eli Lilly and Company Novel imaging agents for detecting neurological dysfunction
US8932557B2 (en) 2008-02-14 2015-01-13 Eli Lilly And Company Imaging agents for detecting neurological dysfunction
KR20110015699A (ko) 2008-06-11 2011-02-16 제넨테크, 인크. 디아자카르바졸 및 사용 방법
JP2011529086A (ja) 2008-07-24 2011-12-01 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド Ad病変を同定するために有用な造影剤
US20100056491A1 (en) * 2008-08-29 2010-03-04 Memory Pharmaceuticals Corporation 4'-amino cyclic compounds having 5-ht6 receptor affinity
US8691187B2 (en) 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
JP2012521988A (ja) 2009-03-23 2012-09-20 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド 神経学的障害を検知するためのイメージング剤
US20110183938A1 (en) 2009-12-16 2011-07-28 Genentech, Inc. 1,7-diazacarbazoles and methods of use
US20150368244A1 (en) 2011-01-31 2015-12-24 Genentech, Inc. Diazacarbazoles and methods of use
NZ714502A (en) * 2011-07-05 2017-04-28 Vertex Pharma Processes and intermediates for producing azaindoles
JP6034005B2 (ja) * 2011-08-03 2016-11-30 出光興産株式会社 ビスカルバゾール誘導体およびこれを用いた有機エレクトロルミネッセンス素子
CN105358558B (zh) * 2013-10-08 2017-09-26 豪夫迈·罗氏有限公司 作为tau‑pet‑配体的二氮杂咔唑衍生物
EA036518B1 (ru) * 2015-02-02 2020-11-18 Юсб Байофарма Спрл Производные 9h-пирролодипиридина
EP3347363B1 (en) * 2015-09-09 2020-01-01 H. Hoffnabb-La Roche Ag N-(3-azabicyclo[3.2.1]octan-8-yl)-8-(4-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[l,5-a]pyridin-2-amine derivatives as gamma-secretase modulators for treating alzheimer's disease

Also Published As

Publication number Publication date
CA3035624A1 (en) 2018-03-15
SG11201901983PA (en) 2019-04-29
IL265013B (en) 2021-09-30
TWI753009B (zh) 2022-01-21
WO2018046428A1 (en) 2018-03-15
EP3510031B1 (en) 2020-12-02
CN109689653A (zh) 2019-04-26
CN109689653B (zh) 2022-04-12
JP2019529401A (ja) 2019-10-17
EP3510031A1 (en) 2019-07-17
AU2017324297B2 (en) 2021-08-05
ES2847903T3 (es) 2021-08-04
BR112019004091B1 (pt) 2023-02-14
US20190300529A1 (en) 2019-10-03
AU2017324297A1 (en) 2019-03-14
HRP20210145T1 (hr) 2021-03-05
JP6997769B2 (ja) 2022-02-10
BR112019004091A2 (pt) 2019-05-28
TW201811787A (zh) 2018-04-01
US11306093B2 (en) 2022-04-19
KR102502701B1 (ko) 2023-02-23
SI3510031T1 (sl) 2021-03-31
PL3510031T3 (pl) 2021-05-31
KR20190044648A (ko) 2019-04-30
MX2019002362A (es) 2019-06-17
AR109586A1 (es) 2018-12-26

Similar Documents

Publication Publication Date Title
WO2013184480A3 (en) Processes to produce certain 2-(pyridine-3-yl)thiazoles
MY175254A (en) Synthesis of lactams
AU2015221439B2 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
IN2012DN03176A (es)
EP4023641A3 (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
JOP20160185B1 (ar) طريقة لتحضير (4s)-4-(4- سيانو-2- ميثوكسي فنيل)-5- إيثوكسي-8،2-داي ميثيل-4،1-داي هيدرو-6،1- نافثيريدين-3- كربوكساميد واسترجاع (4s)-4-(4- سيانو-2- ميثوكسي فنيل)-5- إيثوكسي-8،2- داي ميثيل-4،1- داي هيدرو-6،1- نافثيريدين-3- كربوكساميد بواسطة طرق كهروكيميائية
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
NZ701950A (en) Processes to produce certain 2-(pyridine-3-yl)thiazoles
WO2012004396A3 (en) Process of preparing a thrombin specific inhibitor
WO2014026657A3 (en) A process for the preparation of a derivative of 2-methyl-2'-phenylpropionic acid using new intermediates
MD20120129A2 (en) Process for the preparation of perindopril L-arginine salt
DK1877384T3 (da) Fremgangsmåde til fremstilling af eventuelt 2-substituerede 1,6-dihydro-6-oxo-4-pyrimidincarboxylsyrer
MX2020012083A (es) Metodo de preparacion del inhibidor de alquinilpiridina prolil hidroxilasa.
IN2014DN08732A (es)
JOP20180126A1 (ar) عمليات جديدة من أجل تحضير منشطات محلقة غوانيلات قابلة للذوبان
MX375720B (es) Proceso para preparacion de 2-(6-nitropiridin-3-il)-9h-dipirido[2,3-beta;3',4'-d]pirrol.
EP2135870A4 (en) Process for production of mirtazapine
CN106687441A8 (zh) 用于将第一化合物偶合到第二化合物的方法
EP2952501A3 (en) Anti-cancer dibenzocycloheptane derivatives and a catalytic method for dibenzocycloheptane synthesis and allocolchicinoid synthesis
AU2016374914B2 (en) Method for producing benzoxazole compound
EA201790659A1 (ru) Способ получения сложных эфиров карбоновых кислот в присутствии титансодержащего катализатора
WO2012134102A3 (ko) 노보넨 디에스터 유도체, 이의 제조방법 및 이의 용도
WO2012052939A3 (en) Preparation of bicyclo[2.2.2]octan-2-one compounds
WO2015188243A9 (en) PROCESS FOR PREPARING IMATINIB AND IMATINIB MESYLATE NON-NEEDLE SHAPED α2 FORM
NZ625000A (en) Co-crystals of cyprodinil

Legal Events

Date Code Title Description
FG Grant or registration